Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Potent, nonpeptide angiotensin II receptor antagonists discovered at Chinese university

Dec. 30, 1999

AstraZeneca seeks approval of Atacand HCT in the U.S.

Dec. 30, 1999

Schwarz, ARYx team up to design novel antiarrhythmic drugs

Dec. 30, 1999

CytRx announces Flocor phase III results

Dec. 28, 1999

Opioid receptor ligands from Novo Nordisk useful for vasomotor disturbances

Dec. 27, 1999

Scios's new p38 MAP kinase inhibitors especially useful for cardiovascular disorders

Dec. 27, 1999

Cardioprotective efficacy of NHE-1 inhibitor is superior to that of IPC

Dec. 27, 1999

Myogen achieves financing for oral enoximone pivotal trial

Dec. 27, 1999

MJ-355: a new K(ATP) channel opener with antihypertensive and cardioprotective effects

Dec. 22, 1999

Pretreatment with complement inhibitor significantly reduces cardiac, brain damage following CPB

Dec. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...